A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
Public ClinicalTrials.gov record NCT07357415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the efficacy and safety of different retatrutide dose escalation schemes in participants without type 2 diabetes who have obesity or overweight. Participation in the study will last about 113 weeks.
Study identification
- NCT ID
- NCT07357415
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 23, 2026
- Primary completion
- Sep 30, 2028
- Completion
- Oct 31, 2028
- Last update posted
- Jun 8, 2026
2026 – 2028
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85053 | — |
| Care Access - Huntington Beach | Huntington Beach | California | 92648 | — |
| Los Angeles Institute for Metabolic Research | Los Angeles | California | 90015 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Encore Medical Research - Weston | Weston | Florida | 33331 | — |
| Pacific Diabetes & Endocrine Center | Honolulu | Hawaii | 96817 | — |
| Monroe Biomedical Research - Louisville | Louisville | Kentucky | 40213 | — |
| Brigham and Women's Hospital Diabetes Program | Boston | Massachusetts | 02115 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| NYC Research INC | Long Island City | New York | 11106 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Care Access - Raleigh | Raleigh | North Carolina | 27607 | — |
| New Phase Research and Development | Knoxville | Tennessee | 37909 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Cedar Health Research - Texas Native Health | Dallas | Texas | 75235 | — |
| Cedar Health Research | Dallas | Texas | 75251 | — |
| Cedar Health Research - Fort Worth | Fort Worth | Texas | 76132 | — |
| Advanced Research Institute | Ogden | Utah | 84405 | — |
| Dominion Medical Associates, Inc. | Richmond | Virginia | 23219 | — |
| CAMC Institute for Academic Medicine | Charleston | West Virginia | 25304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07357415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07357415 live on ClinicalTrials.gov.